Multiple cellular and enzymatic targets

Multiple cellular and enzymatic targets is a pharmacological classification rather than a specific biological entity or single protein. It is used to describe the mechanism of action for drugs, particularly non-specific alkylating agents and certain cytotoxic compounds, that interact with a diverse set of intracellular molecules including DNA, RNA, and various functional proteins (DrugBank, 2024). These drugs typically exert their effects by forming covalent bonds with nucleophilic groups, leading to the disruption of essential cellular processes such as replication, transcription, and enzymatic catalysis (NCBI, 2023). Because these agents do not bind to a single specific receptor, they are often characterized by broad-spectrum activity and significant systemic toxicity, which limits their therapeutic index (StatPearls, 2023). In clinical and research databases, this designation highlights the pleiotropic nature of a drug's interactome, where the therapeutic outcome is the result of cumulative damage across multiple cellular components rather than a targeted intervention (PubMed, 2022). This classification is essential for understanding the pharmacodynamics of older chemotherapy agents that lack the precision of modern targeted therapies.

Other names

Multi-targetNon-specific cellular targetsPleiotropic drug targetsNon-specific enzymatic targets

Drugs associated with this designation typically act via non-specific covalent bonding to cellular nucleophiles such as DNA, RNA, and proteins, or by disrupting multiple enzymatic pathways simultaneously (DrugBank, 2024; PubChem, 2024).